• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌的评估与管理

Evaluation and management of hepatocellular carcinoma.

作者信息

Kulik Laura M, Chokechanachaisakul Attasit

机构信息

Kovler Organ Transplantation Center, NMH, Arkes Family Pavilion, Suite 1900, 676 North Saint Clair, Chicago, IL 60611, USA.

Kovler Organ Transplantation Center, NMH, Arkes Family Pavilion, Suite 1900, 676 North Saint Clair, Chicago, IL 60611, USA.

出版信息

Clin Liver Dis. 2015 Feb;19(1):23-43. doi: 10.1016/j.cld.2014.09.002. Epub 2014 Oct 30.

DOI:10.1016/j.cld.2014.09.002
PMID:25454295
Abstract

The burden of hepatocellular carcinoma is rising and anticipated to escalate and while the best chance for long term cure remains transplantation, however the shortage of available organs remains a limitation. Liver directed therapy can serve the role of bridge/downstaging to transplant or as palliative care. Despite an improved overall survival among patients with HCC, due to advancements in surgical techniques, liver directed and systemic therapy, the 5 year overall survival remains low at 18% high-lightening the need for novel therapies. Surveillance for HCC is key to detect disease at an early stage to increase the chances for a potentially curative option.

摘要

肝细胞癌的负担正在上升,预计还会加剧。虽然长期治愈的最佳机会仍然是肝移植,但可用器官的短缺仍是一个限制因素。肝导向治疗可起到作为移植的桥梁/降期治疗或作为姑息治疗的作用。尽管由于手术技术、肝导向治疗和全身治疗的进步,肝癌患者的总体生存率有所提高,但5年总生存率仍低至18%,这凸显了对新型治疗方法的需求。肝癌监测是在早期阶段发现疾病以增加潜在治愈选择机会的关键。

相似文献

1
Evaluation and management of hepatocellular carcinoma.肝细胞癌的评估与管理
Clin Liver Dis. 2015 Feb;19(1):23-43. doi: 10.1016/j.cld.2014.09.002. Epub 2014 Oct 30.
2
Hepatocellular carcinoma: options for diagnosing and managing a deadly disease.肝细胞癌:诊断和治疗致命疾病的选择。
Cleve Clin J Med. 2013 Oct;80(10):645-53. doi: 10.3949/ccjm.80a.12163.
3
Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009.亚洲肝细胞癌的管理:2009年亚洲肿瘤学峰会共识声明
Lancet Oncol. 2009 Nov;10(11):1111-8. doi: 10.1016/S1470-2045(09)70241-4.
4
[Hepatocellular carcinoma, from monitoring to treatment].[肝细胞癌,从监测到治疗]
Soins. 2013 Nov(780):35-7.
5
Established and emerging therapies for hepatocellular carcinoma.用于肝细胞癌的既定和新兴疗法。
Minerva Med. 2010 Dec;101(6):405-18.
6
Hepatocellular carcinoma.肝细胞癌
Clin Liver Dis. 2006 May;10(2):339-51, ix. doi: 10.1016/j.cld.2006.05.012.
7
Hepatocellular carcinoma in viral hepatitis: improving standard therapy.病毒性肝炎中的肝细胞癌:改进标准治疗方法。
Best Pract Res Clin Gastroenterol. 2008;22(6):1137-51. doi: 10.1016/j.bpg.2008.11.005.
8
Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.日本肝细胞癌早期检测监测项目:肝病专科结果
J Clin Gastroenterol. 2006 Nov-Dec;40(10):942-8. doi: 10.1097/01.mcg.0000225675.14594.d6.
9
Management of HCC.肝癌的治疗。
J Hepatol. 2012;56 Suppl 1:S75-87. doi: 10.1016/S0168-8278(12)60009-9.
10
Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma.肝细胞癌的流行病学、筛查、诊断与治疗
Minerva Gastroenterol Dietol. 2009 Jun;55(2):123-38.

引用本文的文献

1
Influence of Pterostilbene on Gene Expression in Liver Cancer: An In Silico Analysis.紫檀芪对肝癌基因表达的影响:一项计算机模拟分析
Cureus. 2024 Jan 28;16(1):e53098. doi: 10.7759/cureus.53098. eCollection 2024 Jan.
2
SAMD13 serves as a useful prognostic biomarker for hepatocellular carcinoma.SAMD13 可作为肝细胞癌有价值的预后生物标志物。
Eur J Med Res. 2023 Nov 15;28(1):514. doi: 10.1186/s40001-023-01347-5.
3
Identification of KRBA1 as a Potential Prognostic Biomarker Associated with Immune Infiltration and m6A Modification in Hepatocellular Carcinoma.
鉴定KRBA1作为与肝细胞癌免疫浸润和m6A修饰相关的潜在预后生物标志物。
J Hepatocell Carcinoma. 2022 May 31;9:497-516. doi: 10.2147/JHC.S363862. eCollection 2022.
4
Recent Advances in Anticancer Activity of Novel Plant Extracts and Compounds from Curcuma longa in Hepatocellular Carcinoma.新型姜黄属植物提取物及化合物在肝癌中抗癌活性的最新进展
J Gastrointest Cancer. 2023 Jun;54(2):368-390. doi: 10.1007/s12029-022-00809-z. Epub 2022 Mar 14.
5
Identification of Immune-Related Prognostic mRNA and lncRNA in Patients with Hepatocellular Carcinoma.肝细胞癌患者免疫相关预后mRNA和lncRNA的鉴定
J Oncol. 2022 Jan 4;2022:5313149. doi: 10.1155/2022/5313149. eCollection 2022.
6
Hypoxia-induced Fascin-1 upregulation is regulated by Akt/Rac1 axis and enhances malignant properties of liver cancer cells via mediating actin cytoskeleton rearrangement and Hippo/YAP activation.缺氧诱导的丝聚蛋白-1上调受Akt/Rac1轴调控,并通过介导肌动蛋白细胞骨架重排和Hippo/YAP激活增强肝癌细胞的恶性特性。
Cell Death Discov. 2021 Dec 11;7(1):385. doi: 10.1038/s41420-021-00778-5.
7
Targeting the NCOA3-SP1-TERT axis for tumor growth in hepatocellular carcinoma.针对肝细胞癌中 NCOA3-SP1-TERT 轴的肿瘤生长。
Cell Death Dis. 2020 Nov 25;11(11):1011. doi: 10.1038/s41419-020-03218-x.
8
MiR-887 Promotes the Progression of Hepatocellular Carcinoma via Targeting VHL.miR-887 通过靶向 VHL 促进肝细胞癌的进展。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820940425. doi: 10.1177/1533033820940425.
9
Whole-exome mutational landscape of metastasis in patient-derived hepatocellular carcinoma cells.患者来源的肝癌细胞转移的全外显子组突变图谱
Genes Dis. 2020 May 15;7(3):380-391. doi: 10.1016/j.gendis.2020.05.003. eCollection 2020 Sep.
10
Curcumin Inhibits Hepatocellular Carcinoma via Regulating miR-21/TIMP3 Axis.姜黄素通过调控miR-21/TIMP3轴抑制肝细胞癌
Evid Based Complement Alternat Med. 2020 Jul 17;2020:2892917. doi: 10.1155/2020/2892917. eCollection 2020.